News

DuPont gets permission to divest alginates business

29 May 2018

DuPont Nutrition & Health has received approval from the European Commission to divest its heritage DuPont N&H Alginates business to JRS Group.

DuPont gets permission to divest alginates business

DuPont Nutrition & Health has received approval from the European Commission to divest its heritage DuPont N&H Alginates business to JRS Group, a manufacturer of functional additives from plant-based raw materials. The divestiture is expected to close in Q3 2018.

The transaction with JRS Group includes the heritage DuPont Alginates business, comprising pure and buffered alginates, a specific portfolio of pectin-alginate blends, the associated Landerneau production site, and customer relationships.

The divestiture was a requirement set out by the EC upon its conditional approval of DuPont’s acquisition of FMC’s Health & Nutrition (H&N) business in 2017.

“The receipt of regulatory approval to divest the heritage DuPont N&H Alginates business is an important step in finalizing our integration of FMC’s Health & Nutrition Business. Our team is dedicated to creating value for our customers through the integration of our new DuPont N&H product portfolio, which combines the heritage portfolios of DuPont N&H, FMC H&N and Dow Food & Pharma to deliver a unique offering in the food ingredients and pharma excipients market,” said Matthias Heinzel, DuPont N&H Business President.

DuPont Nutrition & Health said it will continue to be active in the alginates market after the transaction closes through the FMC Nutrition & Health alginates portfolio.